Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT02332460
Eligibility Criteria:
Inclusion Criteria:
* Patients treated with Infliximab due to chronic inflammatory disease included before start of treatment
* Weight at least 15 kg
* Control groups which may be included for investigations of secondary outcomes: age, gender, disease matched patients not receiving infliximab, healthy blood donors, other patients receiving pneumococci and influenza vaccines
Exclusion Criteria:
* Patients not completing treatment within Health Region
* Patients not able to complete sampling procedure
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02332460
Study Brief:
Protocol Section:
NCT02332460